We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
HealthEquity
HQY
$8.83B
| $2.14M | 0.01% |
22,316
+1,700
| +8% | +$158K |
|
652
Old Republic International
ORI
$10.3B
| $2.14M | 0.01% |
59,171
-6,500
| -10% | -$237K |
|
|
MASI
653
DELISTED
Masimo
MASI
| $2.14M | 0.01% |
12,930
-300
| -2% | -$47.4K |
|
654
Commerce Bancshares
CBSH
$8.61B
| $2.13M | 0.01% |
35,971
+3,306
| +10% | +$199K |
|
655
Immunome
IMNM
$3B
| $2.12M | 0.01% |
200,000
-30,000
| -13% | -$363K |
|
656
Bunge Global
BG
$21.7B
| $2.12M | 0.01% |
27,300
-2,500
| -8% | -$219K |
|
657
Wingstop
WING
$3.1B
| $2.12M | 0.01% |
7,444
| – | – |
|
658
Repligen
RGEN
$9.45B
| $2.11M | 0.01% |
14,633
+1,200
| +9% | +$172K |
|
659
Chemed
CHE
$7.02B
| $2.1M | 0.01% |
3,972
+100
| +3% | +$56.4K |
|
660
Carpenter Technology
CRS
$26.6B
| $2.1M | 0.01% |
12,400
+1,800
| +17% | +$309K |
|
661
Cullen/Frost Bankers
CFR
$10.5B
| $2.1M | 0.01% |
15,616
-700
| -4% | -$91.9K |
|
662
Aaon
AAON
$7.23B
| $2.09M | 0.01% |
17,724
-1,300
| -7% | -$159K |
|
663
Badger Meter
BMI
$3.78B
| $2.07M | 0.01% |
9,749
+840
| +9% | +$183K |
|
|
CMA
664
DELISTED
Comerica
CMA
| $2.07M | 0.01% |
33,400
-4,100
| -11% | -$267K |
|
665
Wyndham Hotels & Resorts
WH
$5.51B
| $2.07M | 0.01% |
20,500
-2,400
| -10% | -$223K |
|
666
Federal Realty Investment Trust
FRT
$10.3B
| $2.06M | 0.01% |
18,400
-5,800
| -24% | -$656K |
|
667
Medpace
MEDP
$16.2B
| $2.06M | 0.01% |
6,200
| – | – |
|
668
Kyndryl
KD
$3.04B
| $2.06M | 0.01% |
59,500
+2,900
| +5% | +$84.4K |
|
669
Rocket Lab Corp
RKLB
$51.2B
| $2.06M | 0.01% |
80,800
+9,100
| +13% | +$160K |
|
670
WIX.com
WIX
$3.35B
| $2.06M | 0.01% |
9,594
+195
| +2% | +$37.3K |
|
671
Abercrombie & Fitch
ANF
$4.84B
| $2.05M | 0.01% |
13,700
+1,500
| +12% | +$219K |
|
672
AGNC Investment
AGNC
$13B
| $2.03M | 0.01% |
220,100
| – | – |
|
673
Fox Class A
FOXA
$27.5B
| $2.03M | 0.01% |
41,704
+27,024
| +184% | +$1.22M |
|
674
Albertsons Companies
ACI
$6.02B
| $2.02M | 0.01% |
102,892
-4,900
| -5% | -$92.9K |
|
675
Simpson Manufacturing
SSD
$8B
| $2M | 0.01% |
12,037
-800
| -6% | -$147K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.